Settlement of liabilities in common stock Right-of-use assets and prepaid expenses recognized in exchange for common stock Right-of-use assets obtained in exchange for lease liabilities Net (decrease) increase in cash, cash equivalents and restricted cashĬash, cash equivalents and restricted cash at beginning of the periodĮffects of exchange rate changes on cash, cash equivalents and restricted cashĬash, cash equivalents and restricted cash at end of the periodĪccrued purchases of property, equipment, and patents Net cash provided by financing activities Proceeds from the issuance of common stock and warrantsĬosts paid on the issuance of common stock and warrants Net cash provided by (used in) investing activities Proceeds from sale of property, plant and equipmentĪcquisition of business, net of cash acquired Purchases of property, plant and equipment Gain on sale of property, plant and equipmentĬhanges in operating assets and liabilities Unrealized foreign currency exchange loss Weighted average number of shares outstanding - basic and dilutedĬONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED)Īdjustments to reconcile net loss to net cash used in operating activities: Total liabilities and stockholders' equityĬONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)įair value gain on changes of own credit risk Issued and outstanding at December 31, 2021Īccumulated other comprehensive income (loss) Outstanding at September 30, 2022, and $.001 par value unlimited shares authorized, 284,573,316 shares Prepaid expenses and other current assetsĬurrent portion of deferred government assistanceĬurrent portion of operating lease liabilitiesĬommon stock - $0.001 par value 1,000,000,000 shares authorized, 361,377,856 shares issued and As of November 9, 2022, common shares outstanding were 361,930,468. The Company has no debt, except for approximately $2.9 million in various interest-free, unsecured loans from ACOA (Atlantic Canada Opportunities Agency). As of September 30, 2022, cash and equivalents totaled approximately $32.2 million, including about $0.4 million in restricted cash. In Q3:22, capital expenditures for purchases of property, plant and equipment were $3,003,699. Net cash used in operating activities during the quarter ended Septemwas $19,513,100, and net cash used in operating activities during the nine months YTD was $48,516,511. For the first nine months of FY 2022, the net loss was $63,892,619, or 20c per share on 316,661,487 weighted average shares, compared to a net loss in the first nine months of FY 2021 of $61,467,070 (which included a $40,540,091 non-cash loss on financial instruments), or 28c per share on 216,135,190 weighted average shares. The Q3:22 net loss was $24,475,320, or 7c per share on 362,260,641 weighted average shares, compared to the Q3:21 net loss of $11,425,248, or 4c per share on 280,080,786 weighted average shares. For the nine months ended September 30, 2022, total revenue grew 388%, to $8,754,434, compared to $1,793,235 in the first nine months of FY 2021. The Q3 2022 financial statements and associated management discussion and analysis for the quarter ended Septemare available on the Investors section of our website as well as on, or on the SEC EDGAR website at In Q3:22, total revenue grew 329% Y/Y, to $2,456,012, compared to $572,612 in Q3:21. The Company will host a webcast on Thursday, November 10, 2022, at 8:00 AM EST. Please visit the Investors section of our website to view the Q3 2022 Shareholder Letter. (the "Company" or "META®") (NASDAQ:MMAT)(FSE:MMAT), a developer of high-performance smart materials and nanocomposites, today announced third quarter FY 2022 results. HALIFAX, NS / ACCESSWIRE / Novem/ Meta Materials Inc.
0 Comments
Leave a Reply. |